Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keyur Patel

Showing results (341-350 of 357) with videos related to

Pageof 36
Sort By:
Hepatology (Baltimore, Md.)|March 3, 2020
Cilofexor, a Nonsteroidal FXR Agonist, in Patients With Noncirrhotic NASH: A Phase 2 Randomized Controlled TrialKeyur Patel, Stephen A Harrison, Magdy Elkhashab, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 14, 2021
Correction to: Myelodysplastic/myeloproliferative neoplasms-unclassifiable with isolated isochromosome 17q represents a distinct clinico-biologic subset: a multi-institutional collaborative study from the Bone Marrow Pathology GroupRashmi Kanagal-Shamanna, Attilio Orazi, Robert P Hasserjian, et al.
Alimentary Pharmacology & Therapeutics|September 9, 2025
Prediction of Hepatocellular Carcinoma and Other Liver-Related Events in Chronic Hepatitis B Patients With Metabolic Dysfunction or Metabolic Dysfunction-Associated Steatotic Liver DiseaseLesley A Patmore, Ivana Carey, Jordan J Feld, et al.
The New England Journal of Medicine|May 30, 2019
Ibrutinib and Venetoclax for First-Line Treatment of CLLNitin Jain, Michael Keating, Philip Thompson, et al.
Cell Reports. Medicine|May 24, 2023
Tumor biology and immune infiltration define primary liver cancer subsets linked to overall survival after immunotherapyAnuradha Budhu, Erica C Pehrsson, Aiwu He, et al.
Nature Communications|July 12, 2018
Integrative genomic analysis of adult mixed phenotype acute leukemia delineates lineage associated molecular subtypesKoichi Takahashi, Feng Wang, Kiyomi Morita, et al.
The Journal of the American Academy of Orthopaedic Surgeons|June 26, 2026
Impact of Intraoperative Neuromonitoring Alert Resolution on Motor Deficits and Short-Term Outcomes After Spine FusionJarod Olson, Jonathan F Dalton, Brandon Martinazzi, et al.
Blood|December 7, 2016
Ph-like acute lymphoblastic leukemia: a high-risk subtype in adultsNitin Jain, Kathryn G Roberts, Elias Jabbour, et al.
JAMA Oncology|June 10, 2021
Ibrutinib Plus Venetoclax for First-line Treatment of Chronic Lymphocytic Leukemia: A Nonrandomized Phase 2 TrialNitin Jain, Michael Keating, Philip Thompson, et al.
Blood Cancer Journal|March 7, 2021
Evolutionary action score identifies a subset of TP53 mutated myelodysplastic syndrome with favorable prognosisRashmi Kanagal-Shamanna, Guillermo Montalban-Bravo, Panagiotis Katsonis, et al.
Pageof 36

Showing results (341-350 of 357) with videos related to

Sort By:
Pageof 36
Hepatology (Baltimore, Md.)|March 3, 2020
Cilofexor, a Nonsteroidal FXR Agonist, in Patients With Noncirrhotic NASH: A Phase 2 Randomized Controlled TrialKeyur Patel, Stephen A Harrison, Magdy Elkhashab, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 14, 2021
Correction to: Myelodysplastic/myeloproliferative neoplasms-unclassifiable with isolated isochromosome 17q represents a distinct clinico-biologic subset: a multi-institutional collaborative study from the Bone Marrow Pathology GroupRashmi Kanagal-Shamanna, Attilio Orazi, Robert P Hasserjian, et al.
Alimentary Pharmacology & Therapeutics|September 9, 2025
Prediction of Hepatocellular Carcinoma and Other Liver-Related Events in Chronic Hepatitis B Patients With Metabolic Dysfunction or Metabolic Dysfunction-Associated Steatotic Liver DiseaseLesley A Patmore, Ivana Carey, Jordan J Feld, et al.
The New England Journal of Medicine|May 30, 2019
Ibrutinib and Venetoclax for First-Line Treatment of CLLNitin Jain, Michael Keating, Philip Thompson, et al.
Cell Reports. Medicine|May 24, 2023
Tumor biology and immune infiltration define primary liver cancer subsets linked to overall survival after immunotherapyAnuradha Budhu, Erica C Pehrsson, Aiwu He, et al.
Nature Communications|July 12, 2018
Integrative genomic analysis of adult mixed phenotype acute leukemia delineates lineage associated molecular subtypesKoichi Takahashi, Feng Wang, Kiyomi Morita, et al.
The Journal of the American Academy of Orthopaedic Surgeons|June 26, 2026
Impact of Intraoperative Neuromonitoring Alert Resolution on Motor Deficits and Short-Term Outcomes After Spine FusionJarod Olson, Jonathan F Dalton, Brandon Martinazzi, et al.
Blood|December 7, 2016
Ph-like acute lymphoblastic leukemia: a high-risk subtype in adultsNitin Jain, Kathryn G Roberts, Elias Jabbour, et al.
JAMA Oncology|June 10, 2021
Ibrutinib Plus Venetoclax for First-line Treatment of Chronic Lymphocytic Leukemia: A Nonrandomized Phase 2 TrialNitin Jain, Michael Keating, Philip Thompson, et al.
Blood Cancer Journal|March 7, 2021
Evolutionary action score identifies a subset of TP53 mutated myelodysplastic syndrome with favorable prognosisRashmi Kanagal-Shamanna, Guillermo Montalban-Bravo, Panagiotis Katsonis, et al.
Pageof 36